在中国,愿意支付癌症预防与治疗费用:对成本效益值的影响
Zixuan Zhao1, Yi Yang2, Weijia Wu2
1Department of Public Administration, School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.
Expert review of pharmacoeconomics & outcomes research
|September 27, 2023
概括
中国的医疗保健政策制定者对癌症预防与治疗的支付意愿 (WTP) 不同. 调查结果表明,为了更细致的方法,需要改进成本效益值 (CET).
科学领域:
- 卫生经济学 卫生经济学
- 公共卫生政策 公共卫生政策
背景情况:
- 在中国,适当的成本效益值 (CET) 的经验证据有限.
- 了解医疗保健政策制定者对资源分配的看法至关重要.
研究的目的:
- 从供应方面 (政策制定者) 估计癌症预防和治疗的支付意愿 (WTP).
- 为了确定WTP是否在癌症预防和治疗场景之间有所不同.
主要方法:
- 在全国智库的79名政府咨询专家中进行了基于网络的调查.
- 使用条件估值方法来评估非市场医疗服务的货币价值.
- 数据是在2022年5月至7月期间收集的.
主要成果:
- 平均WTP估计为一个场景的1.29倍的人均GDP,另一个场景为1.90倍.
- 在两种情景之间观察到WTP的显著差异.
- 愿意为癌症治疗支付费用远远高于愿意为癌症预防.
结论:
- 虽然中国的情景之间的WTP差距比其他国家小,但存在差异.
- 该研究强调需要通过结合预防等特定参数而不是通用值来完善CET发展.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis
380
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
380
Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
Preventive Healthcare Services
1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


